↓ Skip to main content

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
29 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Published in
Journal for Immunotherapy of Cancer, October 2019
DOI 10.1186/s40425-019-0761-3
Pubmed ID
Authors

Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, Eric Vivier

Twitter Demographics

The data shown below were collected from the profiles of 29 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 110 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 20%
Researcher 19 17%
Student > Ph. D. Student 14 13%
Student > Bachelor 14 13%
Other 4 4%
Other 14 13%
Unknown 23 21%
Readers by discipline Count As %
Immunology and Microbiology 22 20%
Biochemistry, Genetics and Molecular Biology 20 18%
Medicine and Dentistry 18 16%
Agricultural and Biological Sciences 13 12%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 12 11%
Unknown 21 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2021.
All research outputs
#1,068,782
of 20,025,283 outputs
Outputs from Journal for Immunotherapy of Cancer
#227
of 2,324 outputs
Outputs of similar age
#31,853
of 347,118 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#36
of 344 outputs
Altmetric has tracked 20,025,283 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,324 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,118 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 344 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.